ABBOTT LABORATORIES — Director's Dealing 2008

Feb 21, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-11

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-02-11	Common shares without par value	G	1056	—	Disposed	294355	Direct
2008-02-15	Common shares without par value	A	31400	$55.56	Acquired	325755	Direct
2008-02-17	Common shares without par value	F	3761	$55.55	Disposed	321994	Direct
2008-02-18	Common shares without par value	F	1223	$55.55	Disposed	320771	Direct
2008-02-11	Common shares without par value	G	352	—	Acquired	1197	Indirect
2008-02-11	Common shares without par value	G	352	—	Acquired	1197	Indirect
2008-02-11	Common shares without par value	G	352	—	Acquired	1197	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-02-15	Option (right to buy)	$55.56	A	127500	Acquired	2018-02-14	common shares (127500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	19963	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 14, 2008

F3: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,500 on 2/15/09, 42,500 on 2/15/10 and 42,500 on 2/15/11.